Treatment of homologous recombination deficient cancers Grant US-11897925-B2 United States of America 13 Feb 2024
NOVEL PLX1 PROTEIN DEGRADATION-INDUCING COMPOUND Application WO-2023277583-A1 World Intellectual Property Organisation (WIPO) 05 Jan 2023
PHARMACEUTICAL COMPOSITION COMPRISING IU1-LINEAGE UBIQUITIN-SPECIFIC PROTEASE 14… Application WO-2022250363-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
CEREBLON E3 LIGASE INHIBITORS Application WO-2021041664-A1 World Intellectual Property Organisation (WIPO) 04 Mar 2021